Zurich consensus: German expert opinion on the St. Gallen votes on 15 march 2009 (11th international conference at St. Gallen: Primary therapy of early breast cancer)

Matthias W. Beckmann, Jens Uwe Blohmer, Serban Dan Costa, Klaus Diedrich, Ingo Diel, Wolfgang Eiermann, Klaus Friese, Bernd Gerber, Nadia Harbeck, Joern Hilfrich, Wolfgang Janni, Fritz Jaenicke, Walter Jonat, Manfred Kaufmann, Marion Kiechle, Uwe Koehler, Rolf Kreienberg, Gunter Von Minckwitz, Volker Moebus, Ulrike NitzAndreas Schneeweiss, Christoph Thomssen, Diethelm Wallwiener

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

A German working group of 23 breast cancer experts discussed the results from the vote at this year's St. Gallen Consensus Conference on Primary Therapy for Early Breast Cancer (March 11-14, 2009) and came up with some concrete recommendations for day-to-day therapeutic decisions in Germany. Due the fact that the concept of the St. Gallen Consensus Conference merely allows for a minimal consensus, the objective of the working group was to provide practice-related recommendations for day-to-day clinical decisions in Germany. One area of emphasis at St. Gallen was tumor biology as a starting point for reaching individual therapeutic decisions. Intensive discussion was necessary with respect to the clinical relevance of predictive and prognostic factors. A new addition to the area of systemic therapy was a first-ever discussion of the adjuvant administration of bisphosponates and the fact that therapy with trastuzumab in HER2 overexpressing breast cancer has been defined as the standard for neoadjuvant therapy. The value of taxanes as a component of (neo)adjuvant chemotherapy as well as the value of aromatase inhibitors for the endocrine adjuvant treatment of postmenopausal patients were affirmed.

Original languageEnglish
Pages (from-to)109-116
Number of pages8
JournalBreast Care
Volume4
Issue number2
DOIs
StatePublished - May 2009

Fingerprint

Dive into the research topics of 'Zurich consensus: German expert opinion on the St. Gallen votes on 15 march 2009 (11th international conference at St. Gallen: Primary therapy of early breast cancer)'. Together they form a unique fingerprint.

Cite this